More than 80% of Dravet syndrome patients have de novo heterozygous missense and truncation mutations in SCN1A, suggesting haploinsufficiency of SCN1A as the genetic cause10. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.